Moonlake Immunotherapeutics
Forward trial catalysts linked to MLTX
CSA tracks 3 forward catalysts for Moonlake Immunotherapeutics across 1 asset, spanning Phase 3. The nearest is a readout expected Jan 15, 2027 (day precision). Confidence across its tracked catalysts breaks down as 3 medium. Tracked indications include Arthritis, Psoriatic, Hidradenitis Suppurativa.
MLTX in the full snapshot
The free sample on this page is a slice. In the current full CSA snapshot, Moonlake Immunotherapeutics has:
Forward catalysts by year
Every catalyst in the snapshot comes with its date, date confidence and source link.
5 trials behind these assets
| Asset | Trial | Phase | Status | Primary completion | Role | Lead sponsor | Condition(s) |
|---|---|---|---|---|---|---|---|
| sonelokimab | NCT06768671 | Phase 3 | Active, not recruiting | 2026-09-28 | Experimental | MoonLake Immunotherapeutics AG | Hidradenitis Suppurativa |
| sonelokimab | NCT06641089 catalyst | Phase 3 | Recruiting | 2027-01-15 | Experimental | MoonLake Immunotherapeutics AG | Arthritis, Psoriatic |
| sonelokimab | NCT06641076 catalyst | Phase 3 | Active, not recruiting | 2027-02-04 | Experimental | MoonLake Immunotherapeutics AG | Arthritis, Psoriatic |
| sonelokimab | NCT07223138 catalyst | Phase 3 | Enrolling by invitation | 2028-02-04 | Experimental | MoonLake Immunotherapeutics AG | Arthritis, Psoriatic |
| sonelokimab | NCT07007637 | Phase 3 | Enrolling by invitation | 2028-06-13 | Experimental | MoonLake Immunotherapeutics AG | Hidradenitis Suppurativa |
Every trial the CSA sample links to MLTX's tracked assets.
Conditions studied
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This sponsor's catalysts are a slice of the free CSA sample. The full snapshot covers active, industry-sponsored Phase 3 trials in cardiometabolic, oncology and immunology. Every forward catalyst carries its date, confidence grade and source link, and is linked to its sponsor's ticker when the sponsor is a listed company.
Get the full dataset — $499 →